Comparison of two methods for enumerating circulating tumor cells in carcinoma patients

被引:119
作者
Balic, M
Dandachi, N
Hofmann, G
Samonigg, H
Loibner, H
Obwaller, A
van der Kooi, A
Tibbe, AGJ
Doyle, GV
Terstappen, LWMM
Bauernhofer, T
机构
[1] Univ Hosp Graz, Dept Clin Oncol, Graz, Austria
[2] Igeneon AG, Vienna, Austria
[3] Immunicon Europe, Enschede, Netherlands
[4] Immunicon Corp, Huntingdon Valley, PA USA
关键词
circulating tumor cells; tumor cell enrichment; peripheral blood; minimal residual disease;
D O I
10.1002/cyto.b.20065
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Monitoring of circulating tumor cells (CTCs) in blood of carcinoma patients treated with novel compounds may be a measurement of treatment effectiveness. Before it can be used clinically, a reliably method is needed to enumerate CTCs. We compared two methods for CTC enumeration, Onko-Quick and the CellSearch system. Methods: We drew 22.5 ml of blood into three CellSave tubes from 15 healthy donors and 61 patients with metastatic carcinoma. After pooling, 15 ml was processed with OncoQuick and 7.5 ml with CellSearch. Results: With both methods no CTCs were found in healthy donors. At least one CTC was detected in 14 of 61 patients (23%) with OncoQuick and 33 of 61 patients (54%) with CellSearch (P < 0.0001). The number of CTCs detected was larger for CellSearch (mean 20 CTCs/7.5 ml of blood) than for OncoQuick (3 CTCs/7.5 ml; P < 0.0001). Conclusion: The CellSearch system is a more accurate and sensitive method to enumerate CTCs. Further studies are warranted to evaluate CTC enumeration by the CellSearch system as a monitoring tool for the evaluation of the efficacy of novel anticancer agents. (c) 2005 international Society for Analytical Cytology.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 32 条
  • [1] Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
    Allard, WJ
    Matera, J
    Miller, MC
    Repollet, M
    Connelly, MC
    Rao, C
    Tibbe, AGJ
    Uhr, JW
    Terstappen, LWMM
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (20) : 6897 - 6904
  • [2] Bauernhofer T, 2005, ONCOL REP, V13, P179
  • [3] A TEST FOR SYMMETRY IN CONTINGENCY TABLES
    BOWKER, AH
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1948, 43 (244) : 572 - 574
  • [4] Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapy
    Braun, S
    Vogl, FD
    Janni, W
    Marth, C
    Schlimok, G
    Pantel, K
    [J]. BREAST, 2003, 12 (06) : 397 - 404
  • [5] Occult metastases: Real harm or false alarm?
    Cote, RJ
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (02) : 332 - 333
  • [6] Circulating tumor cells, disease progression, and survival in metastatic breast cancer
    Cristofanilli, M
    Budd, GT
    Ellis, MJ
    Stopeck, A
    Matera, J
    Miller, MC
    Reuben, JM
    Doyle, GV
    Allard, WJ
    Terstappen, LWMM
    Hayes, DF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) : 781 - 791
  • [7] CRISTOFANILLI M, 2004, AACR
  • [8] Minimal residual disease in gastric cancer: Evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow
    Heiss, MM
    Simon, EH
    Beyer, BCM
    Gruetzner, KU
    Tarabichi, A
    Babic, R
    Schildberg, FW
    Allgayer, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) : 2005 - 2016
  • [9] Kasimir-Bauer S, 2002, INT J ONCOL, V20, P1027
  • [10] Immunomagnetic tumor cell selection -: implications for the detection of disseminated cancer cells
    Krüger, W
    Datta, C
    Badbaran, A
    Tögel, F
    Gutensohn, K
    Carrero, I
    Kröger, N
    Jänicke, F
    Zander, AR
    [J]. TRANSFUSION, 2000, 40 (12) : 1489 - 1493